This firm fixed-price purchase order for $14,943.24 was awarded by the Defense Health Agency to Qiagen, LLC, a division of Qiagen N.V., to provide maintenance services for three QIAGEN EZ1 Advanced XL automated nucleic acid systems. The contract has an ultimate completion date of September 29, 2025. This award is not associated with a set-aside program. Qiagen is an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academics, and...
This is a firm fixed-price purchase order awarded by the U.S. Navy Bureau of Medicine and Surgery to Qiagen, LLC, a division of the international diagnostics company Qiagen N.V. The $10,546.00 contract is for QIAXTRACTOR/QIACUBE HT SERVICE, which are likely equipment maintenance and service support for Qiagen's sample processing and diagnostic systems used in federal biomedical research, public health, and healthcare programs. Qiagen has a history of providing a range of products and services to...
This is a Firm Fixed Price purchase order awarded by the Bureau of Medicine and Surgery, a component of the U.S. Department of Defense, to Qiagen, LLC for the "EXERCISE FULL AGREEMENT FOR EZ1 ADVANCED" contract. The contract has a ceiling value of $4,909.67 and a performance period ending on April 11, 2025. This award is not associated with any set-aside program. Qiagen, LLC is a division of Qiagen N.V., an international provider of sample and assay technologies for molecular...
This is a $97,350.04 firm fixed-price purchase order awarded by the Defense Health Agency to Qiagen, LLC, a subsidiary of the biotechnology company Qiagen N.V. The contract is for QIAGEN EQUIPMENT MAINTENANCE SERVICES and has a period of performance through September 28, 2024. No set-aside designation was used. Qiagen is a major provider of sample and assay technologies to federal agencies, supporting programs related to biomedical research, public health, law enforcement, and healthcare. This...
This federal contract award was issued by the Bureau of Medicine and Surgery, a component of the U.S. Department of Defense, to Qiagen, LLC, a subsidiary of the biotechnology company Qiagen N.V. The $1,897 firm fixed-price purchase order is for labor hours (CLIN 9236439) with a period of performance through September 29, 2019. Qiagen is an established provider of sample and assay technologies supporting federal agencies' biomedical research, public health, law enforcement, and healthcare...
The Department of the Navy Bureau of Medicine and Surgery awarded a firm-fixed-price purchase order contract to Qiagen, LLC, a division of Qiagen N.V., an international provider of sample and assay technologies. The $5,356 contract has a period of performance through April 11, 2025 and does not have a set-aside designation. Qiagen is a manufacturer of goods and has provided a range of products and services to support federal agencies' biomedical research, public health, law enforcement, and...
This firm fixed-price purchase order contract was awarded by the Defense Health Agency to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics and life sciences products. The $211,853.58 contract is for QCII ONE PRECUR 301-600 TESTING and has a performance period ending on May 31, 2027. Qiagen, LLC is a subsidiary of the multinational biotechnology company Qiagen N.V., which has a substantial portfolio of federal contracts and grants for providing specialized equipment,...
This is a firm-fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a division of the international life sciences company Qiagen N.V. The contract, valued at $11,047.00, is for a one-year preventative maintenance agreement covering the EZ1 and EZ2 Connect sample prep instruments from August 16, 2024 to August 15, 2025. Qiagen is an experienced federal contractor, providing a range of sample preparation and molecular diagnostics products...
This $83,927.20 firm fixed-price purchase order was awarded by the Defense Health Agency (DHA), a component of the U.S. Department of Defense, to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The contract is for the delivery of EZ1 ADVANCED XL equipment, which is used for DNA/RNA extraction and sample preparation. This purchase order is not associated with a set-aside program. Qiagen has a history of providing specialized products and services to support...
This contract was awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services, to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The contract is for preventative maintenance coverage on Qiagen's EZ2 and QIAcell laboratory equipment, with a firm fixed price of $11,517.91 and a period of performance from November 19, 2024 to November 18, 2025. Qiagen is an experienced federal contractor, having...